271 related articles for article (PubMed ID: 17563154)
21. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
[TBL] [Abstract][Full Text] [Related]
22. Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.
Wichmann S; Bornstein SR; Lorenz T; Petrowski K
Transl Psychiatry; 2018 Feb; 8(1):37. PubMed ID: 29391399
[TBL] [Abstract][Full Text] [Related]
23. Treatment-resistant panic disorder.
Bandelow B; Rüther E
CNS Spectr; 2004 Oct; 9(10):725-39. PubMed ID: 15448584
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder.
van Apeldoorn FJ; Stant AD; van Hout WJ; Mersch PP; den Boer JA
Acta Psychiatr Scand; 2014 Apr; 129(4):286-95. PubMed ID: 23834587
[TBL] [Abstract][Full Text] [Related]
25. Combined antidepressants and CBT for panic disorder with agoraphobia.
Coupland NJ
J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
[No Abstract] [Full Text] [Related]
26. A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder.
Roy-Byrne PP; Craske MG; Stein MB; Sullivan G; Bystritsky A; Katon W; Golinelli D; Sherbourne CD
Arch Gen Psychiatry; 2005 Mar; 62(3):290-8. PubMed ID: 15753242
[TBL] [Abstract][Full Text] [Related]
27. Psychopathology of panic attacks in panic disorder.
Uhlenhuth EH; Leon AC; Matuzas W
J Affect Disord; 2006 May; 92(1):55-62. PubMed ID: 16448702
[TBL] [Abstract][Full Text] [Related]
28. [Panic disorder].
Finnish Medical Society Duodecim and The Finnish Academy
Duodecim; 2000; 116(22):2534-41. PubMed ID: 12053350
[No Abstract] [Full Text] [Related]
29. Effect of antipanic treatment on response to carbon dioxide.
Gorman JM; Browne ST; Papp LA; Martinez J; Welkowitz L; Coplan JD; Goetz RR; Kent J; Klein DF
Biol Psychiatry; 1997 Dec; 42(11):982-91. PubMed ID: 9386849
[TBL] [Abstract][Full Text] [Related]
30. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.
Furukawa TA; Katherine Shear M; Barlow DH; Gorman JM; Woods SW; Money R; Etschel E; Engel RR; Leucht S
Depress Anxiety; 2009; 26(10):922-9. PubMed ID: 19006198
[TBL] [Abstract][Full Text] [Related]
31. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of the cost and the effectiveness of a psychotherapy for panic disorder with agoraphobia (PDA) versus a treatment combining pharmacotherapy and psychotherapy].
Marchand A; Germain V; Reinharz D; Mainguy N; Landry P
Sante Ment Que; 2004; 29(2):201-20. PubMed ID: 15928793
[TBL] [Abstract][Full Text] [Related]
33. Temporal patterns of change in panic disorder during cognitive behaviour therapy: an Indian study.
Manjula M; Prasadarao PS; Kumaraiah V; Raguram R
Behav Cogn Psychother; 2014 Sep; 42(5):513-25. PubMed ID: 23905590
[TBL] [Abstract][Full Text] [Related]
34. The effect of Korean-group cognitive behavioural therapy among patients with panic disorder in clinic settings.
Choi YS; Lee EJ; Cho Y
J Psychiatr Ment Health Nurs; 2017 Feb; 24(1):28-40. PubMed ID: 27774709
[TBL] [Abstract][Full Text] [Related]
35. Effects of panic disorder treatments on personality disorder characteristics.
Hofmann SG; Shear MK; Barlow DH; Gorman JM; Hershberger D; Patterson M; Woods SW
Depress Anxiety; 1998; 8(1):14-20. PubMed ID: 9750974
[TBL] [Abstract][Full Text] [Related]
36. Cognitive-behavior therapy versus pharmacotherapy: Now that the jury's returned its verdict, it's time to present the rest of the evidence.
Jacobson NS; Hollon SD
J Consult Clin Psychol; 1996 Feb; 64(1):74-80. PubMed ID: 8907086
[TBL] [Abstract][Full Text] [Related]
37. Cognitive treatment for panic disorder.
Gelder MG; Clark DM; Salkovskis P
J Psychiatr Res; 1993; 27 Suppl 1():171-8. PubMed ID: 8145177
[TBL] [Abstract][Full Text] [Related]
38. Relapse following combined treatment discontinuation in a placebo-controlled trial for panic disorder.
Raffa SD; Stoddard JA; White KS; Barlow DH; Gorman JM; Shear MK; Woods SW
J Nerv Ment Dis; 2008 Jul; 196(7):548-55. PubMed ID: 18626295
[TBL] [Abstract][Full Text] [Related]
39. Can pill placebo augment cognitive-behavior therapy for panic disorder?
Furukawa TA; Watanabe N; Omori IM; Churchill R
BMC Psychiatry; 2007 Dec; 7():73. PubMed ID: 18093337
[TBL] [Abstract][Full Text] [Related]
40. Is internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?
Kiropoulos LA; Klein B; Austin DW; Gilson K; Pier C; Mitchell J; Ciechomski L
J Anxiety Disord; 2008 Dec; 22(8):1273-84. PubMed ID: 18289829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
